Patients with chronic spontaneous urticaria experienced relief in itch and hives by day 3 with povorcitinib, according to ...
In today’s Pharma Pulse, the FDA approves Amgen’s Uplizna (inebilizumab-cdon), the first CD19-targeted therapy for gMG with convenient twice-yearly dosing, and much more.
ORLADEYO now first and only targeted oral prophylactic therapy for patients with HAE aged 2 and older – -Oral pellet formulation provides ...
Around 88% of primary care providers managing patients with uncontrolled asthma reported being unfamiliar or only somewhat ...
5don MSN
Switch off your allergies for years without daily pills? Know the treatment backed by WHO and AAAAI
Allergy shots and drops offer a transformative solution for millions. Major health organisations globally endorse this treatment. It goes beyond symptom relief, reprogramming the immune system for ...
Personal narratives on allergy and asthma conditions which contained inaccuracies gained the most traction online.
7d
Rethinking long-term allergy treatments: Experimental vaccine protects against anaphylaxis in mice
Researchers led by the Institut Pasteur, Université Paris, have developed a vaccine that elicits anti-Immunoglobulin E ...
Urticaria updates from ACAAI 2025 include data on dupilumab for chronic urticaria, the relative effectiveness of 55 ...
To understand how one can regulate asthma symptoms and prevent flare-ups, HT Lifestyle connected with Dr Bharat Gopal, senior director- respiratory & sleep medicine at Medanta, Gurugram, who ...
Objectives This study aimed to evaluate the associations between inhaled corticosteroids (ICSs) and adverse events (AEs) in adults with asthma or chronic obstructive pulmonary disease (COPD) and to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback